Overview
Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)
Status:
Unknown status
Unknown status
Trial end date:
2012-12-01
2012-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate the efficacy of BAI Plus 3DCRT in local advanced NSCLC.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Third Military Medical UniversityTreatments:
Gemcitabine
Nedaplatin
Criteria
Inclusion Criteria:- stage IIIA&IIIB NSCLC
- male or female, Age ≥18Years, ≤70Years
- Life expectation of at least 12weeks.
- PS performance 0-2
- Measurable disease according to the Response Evaluation Criteria in Solid Tumours (
RECIST)
Exclusion Criteria:
- Patient with prior chemotherapy or radiology for IIIA or IIIB NSCLC